Jim Cramer on Eli Lilly (LLY) after Trump picked RFK Jr. to run HHS
Enthusiasm for Club holding Eli Lilly needs to be tempered — at least for now — as Wall Street grapples with the possibility of a major shakeup to health policy …
Novo Nordisk A/S
Amgen stock falls on weight loss drug’s bone density loss data
Omar Marques | Lightrocket | Getty Images Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental …
Weight loss drug race heats up with obesity pill data
Aykut Karahan | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe …
Wegovy may reduce knee pain in patients with osteoarthritis, obesity
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance …
Novo Nordisk’s Ozempic, Wegovy now available after shortages
Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images All doses …
Novo Nordisk’s Ozempic may reduce risk of Alzheimer’s disease: study
Steve Christo – Corbis | Corbis News | Getty Images Novo Nordisk‘s blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer’s disease, suggesting its potential to delay or …
Weight loss drugs may cut alcohol, opioid use
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters A version of this article first …
Novo Nordisk asks FDA to ban compounded Ozempic, Wegovy copies
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent …
Medicare weight loss drug coverage could cost $34 billion
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Reuters A version of this article first appeared …
Novo and Eli contender Zealand Pharma targets ‘next generation’ of obesity drugs
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly. CEO Adam Steensberg told …